Aratana Therapeutics, Inc. Asset Turnover Ratio (PETX), as of first quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aratana Therapeutics, Inc.  (PETX)
 

Aratana Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aratana Therapeutics, Inc. asset turnover ratio, the ability of Aratana Therapeutics, Inc.'s assets to generate revenue in the first quarter 2019, increased sequentially to 0.32 in the first quarter (Mar 31 2019), yet the ratio remained below the average, as PETX's position remain challenging.

Within sector 126 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2019 compared to the preceding quarter from 2678 to 2823.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PETX Asset Turnover Ratio (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Asset Change -22.25 % -21.27 % -3.59 % -16.2 % 0.01 %
Y / Y Revenue Change 82.04 % -53.08 % 249.75 % -4.85 % 6.53 %
Asset Turnover Ratio (TTM) 0.32 0.28 0.3 0.19 0.18
PETX's Total Ranking # 2823 # 2678 # 2684 # 2683 # 2823
Seq. Asset Change -1.62 % -23.87 % 9.24 % -4.97 % -0.38 %
Seq. Revenue Change 50.02 % -77.24 % 339.18 % 21.4 % -61.34 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 127
Healthcare Sector # 349
Overall Market # 2823

Asset Turnover Ratio Statistics
High Average Low
1488.23 128.67 -0.09
(Sep 30 2016)   (Sep 30 2014)




PETX Company Profile • Back to PETX Efficiency Comparisons • Compare PETX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2019 Assets at quarter ending Mar 31 2019
Inogen Inc   1.02 $ 369.262  Millions$ 363.460  Millions
Invacare Holdings Corporation  1.01 $ 958.706  Millions$ 945.942  Millions
Ufp Technologies Inc   1.01 $ 194.852  Millions$ 192.341  Millions
Lakeland Industries Inc   1.01 $ 99.351  Millions$ 98.273  Millions
Biomerica Inc   1.00 $ 5.165  Millions$ 5.149  Millions
Arena Pharmaceuticals Inc   1.00 $ 817.272  Millions$ 816.138  Millions
Lifeloc Technologies Inc   1.00 $ 8.305  Millions$ 8.294  Millions
United Cannabis Corp  0.99 $ 11.391  Millions$ 11.476  Millions
U S Physical Therapy Inc  0.99 $ 461.800  Millions$ 465.441  Millions
Orthofix Medical Inc   0.99 $ 453.445  Millions$ 459.472  Millions
Pressure Biosciences Inc   0.99 $ 2.357  Millions$ 2.389  Millions
Icagen, Inc.  0.98 $ 13.963  Millions$ 14.199  Millions
Glaukos Corp  0.98 $ 195.171  Millions$ 199.149  Millions
Seaspine Holdings Corporation  0.97 $ 146.418  Millions$ 150.965  Millions
Xtant Medical Holdings Inc   0.96 $ 70.995  Millions$ 73.886  Millions
Bruker Corporation  0.95 $ 1,925.300  Millions$ 2,016.550  Millions
Crh Medical Corporation  0.95 $ 197.931  Millions$ 208.237  Millions
Chembio Diagnostics Inc   0.95 $ 34.169  Millions$ 35.980  Millions
Veracyte Inc   0.95 $ 101.496  Millions$ 107.178  Millions
Alimera Sciences Inc  0.94 $ 50.058  Millions$ 53.114  Millions
Pediatrix Medical Group Inc   0.93 $ 5,409.019  Millions$ 5,834.883  Millions
Varian Medical Systems Inc   0.92 $ 3,031.100  Millions$ 3,296.375  Millions
Clearpoint Neuro Inc   0.92 $ 8.202  Millions$ 8.937  Millions
Retractable Technologies Inc  0.92 $ 33.534  Millions$ 36.634  Millions
Penumbra Inc  0.90 $ 470.676  Millions$ 521.029  Millions
Cantel Medical Corp   0.90 $ 907.533  Millions$ 1,008.033  Millions
West Pharmaceutical Services Inc   0.89 $ 1,745.200  Millions$ 1,958.725  Millions
Icad Inc  0.89 $ 26.479  Millions$ 29.885  Millions
Organogenesis Holdings Inc   0.89 $ 215.043  Millions$ 242.855  Millions
Antares Pharma Inc   0.88 $ 74.137  Millions$ 83.858  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.